Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?

J Cardiovasc Pharmacol. 2012 Mar;59(3):298-9. doi: 10.1097/FJC.0b013e3182499e9a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Clinical Trials as Topic / methods
  • Drug Evaluation, Preclinical / methods
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
  • Humans
  • Isoxazoles / administration & dosage
  • Isoxazoles / adverse effects*
  • Long QT Syndrome / chemically induced*
  • Paliperidone Palmitate
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Risk Factors

Substances

  • Antipsychotic Agents
  • Ether-A-Go-Go Potassium Channels
  • Isoxazoles
  • Pyrimidines
  • Paliperidone Palmitate